Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Haustermans, K" or (type any "bookEditor journalEditor issueEditor" and editor="Hausterma...

Add to list
Risk adjusted benchmarking of clinical anastomotic leakage rate after total mesorectal excision in the context of an improvement project

F Penninckx, K Beirens, S Fieuws, Wim Ceelen (UGent) , P Demetter, K Haustermans, J Van de Stadt and K Vindevoghel

(2012) COLORECTAL DISEASE. 14(7). p.E413-E421
Add to list
- Journal Article
- A1
- open access
Quality of care indicators in rectal cancer

P Demetter, Wim Ceelen (UGent) , E Danse, K Haustermans, A Jouret-Mourin, A Kartheuser, Stéphanie Laurent (UGent) , G Molle, N Nagy, P Scalliet, et al.

(2011) ACTA GASTRO-ENTEROLOGICA BELGICA. 74(3). p.445-450
Add to list
- Journal Article
- A1
Double blind randomized phase II study with radiation+5-fluorouracil +/- celecoxib for resectable rectal cancer

A Debucquoy, S Roels, L Goethals, Louis Libbrecht (UGent) , E Van Cutsem, K Geboes, F Penninckx, A D'Hoore, WH McBride and K Haustermans

(2009) RADIOTHERAPY AND ONCOLOGY. 93(2). p.273-278
Add to list
- Journal Article
- A1
Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer

A Debucquoy, K Haustermans, A Daemen, S Aydin, Louis Libbrecht (UGent) , O Gevaert, B De Moor, S Tejpar, WH McBride, F Penninckx, et al.

(2009) JOURNAL OF CLINICAL ONCOLOGY. 27(17). p.2751-2757
Add to list
- Conference Paper
- C1
Adjuvant chemoradiation alone versus chemoradiation after curative resection for pancreatic cancer: feasibility results of a randomised EORTC/FFCD/GERCOR study (40013/22012/0304)

J VAN LAETHEM, E VAN CUTSEM, P HAMMEL, F MORNEX, D AZRIA, G VAN TIENHOVEN, Marc Peeters (UGent) , Marleen Praet, V BUDACH and K HAUSTERMANS

(2008) Journal of Clinical Oncology. 26. p.4514-4514
Add to list
- Conference Paper
- C1
Adjuvant chemoradiation after curative resection for pancreatic cancer is feasible: results of a randomised EORTC/FFCD/GERCOR study

J VAN LAETHEM, E VAN CUTSEM, P HAMMEL, D AZRIA, F MORNEX, G VAN TIENHOVEN, Marc Peeters (UGent) , P VERGAUWEN, V BUDACH, L COLLETTE, et al.

(2008) Annals of Onology. 19(Suppl 6). p.008-008
Add to list
- Conference Paper
- C1
Adjuvant chemotherapy alone versus chemoradiation after curative resection for pancreatic cancer: feasibility results of a randomised EORTC/FFCD/GERCOR phase I/II study (40013/22012/0304)

J VAN LAETHEM, E VAN CUSTEM, P HAMMEL, F MORNEX, D ARZIA, G VAN TIENHOVEN, Marc Peeters (UGent) , Marleen Praet, V BUDACH and K HAUSTERMANS

(2007) Journal Clinical Oncology. 25.
Add to list
- Journal Article
- A1
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer

JP MACHIELS, C SEMPOUX, P SCALLIET, JC COCHE, Y HUMBLET, E VAN CUTSEM, J KERGER, JL CANON, Marc Peeters (UGent) , S AYDIN, et al.

(2007) ANNALS OF ONCOLOGY. 18(4). p.738-744
Add to list
- Journal Article
- A1
Definition and delineation of the clinical target volume for rectal cancer

S ROELS, WIM DUTHOY, K HAUSTERMANS, F PENNINCKX, V VANDECAVEYE, Tom Boterberg (UGent) and Wilfried De Neve (UGent)

(2006) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 65(4). p.1129-1142
Add to list
- Journal Article
- A1
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

M BOLLA, H VAN POPPEL, L COLLETTE, P VAN CANGH, K VEKEMANS, L DA POZZO, TM DE REIJKE, Antony Verbaeys (UGent) , JF BOSSET, R VAN VELTHOVEN, et al.

(2005) LANCET. 366(9485). p.572-578

Academic Bibliography

Risk adjusted benchmarking of clinical anastomotic leakage rate after total mesorectal excision in the context of an improvement project

Quality of care indicators in rectal cancer

Double blind randomized phase II study with radiation+5-fluorouracil +/- celecoxib for resectable rectal cancer

Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer

Adjuvant chemoradiation alone versus chemoradiation after curative resection for pancreatic cancer: feasibility results of a randomised EORTC/FFCD/GERCOR study (40013/22012/0304)

Adjuvant chemoradiation after curative resection for pancreatic cancer is feasible: results of a randomised EORTC/FFCD/GERCOR study

Adjuvant chemotherapy alone versus chemoradiation after curative resection for pancreatic cancer: feasibility results of a randomised EORTC/FFCD/GERCOR phase I/II study (40013/22012/0304)

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer

Definition and delineation of the clinical target volume for rectal cancer

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

Contents

Support

Contact